Atlas Trials

Prospective Trial to Evaluate the Safety and Efficacy to Treat Esophageal Cancer Using 5-FU, Oxaliplatin, and Docetaxel

Clinical trial NCT04699994 · UNKNOWN

Trial details

NCT number
NCT04699994
Sponsor
Keio University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma
Start date
2020-06-25
Primary completion
2024-10-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.